Nephris

Developer of therapies for chronic kidney disease in diabetic patients

placeMilano, Umbria, Italy calendar_todayFounded 2021 language nephris.com

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 17 times.

YearFilings
20231
20242
20253
20261

Investor mix

1 investor on record; lead investors include Sofinnova Partners.

Investor typeCountShare
Venture capital1100%
Coming soon